Annual General Meeting

Invitation for the annual general meeting of Merck KGaA, Darmstadt, Germany, on 27 April 2018

Invitation for the annual general meeting (short version)

Annual report of Merck KGaA, Darmstadt, Germany, for the fiscal year 2017 including the consolidated financial statements, combined management report and supervisory board report

Single entity financial statements of Merck KGaA, Darmstadt, Germany, for the fiscal year 2017 including the combined management report and the supervisory board report

PDF

Information relating to agenda item 8 (Revocation of an existing authorization and creation of a new authorization to issue, inter alia, warrant and/or convertible bonds, creation of contingent capital and amendment of the Articles of Association)

Report of the Executive Board to the Annual General Meeting on agenda item 8 in accordance with Section 278 (3) and Section 221 (4) sentence 2 German Stock Corporation Act (Aktiengesetz – AktG) in conjunction with Section 186 (4) sentence 2 AktG

English (PDF)
German (PDF)

Information relating to agenda item 9 (Approval of two Hive-Down and Transfer Agreements and three Business Lease Agreements)

Overview with regard to agenda item 9 (voluntary additional information for our shareholders)

Joint report to the annual general meeting on the restructuring of the operating business of Merck KGaA, Darmstadt, Germany in the business sectors Healthcare, Life Science and Performance Materials

Framework deed no. 92/2018 of 1st/2nd March 2018 of the notary Dr. Andreas von Werder with the notarisation of the Operational Hive-Down Agreement, the Holding Hive-Down Agreement and the business lease agreements

Hive-down and transfer agreement between Merck KGaA, Darmstadt, Germany, and Merck Healthcare Germany GmbH, Darmstadt, Germany, Merck Life Science Germany GmbH, Darmstadt, Germany, and Merck Performance Materials Germany GmbH, Darmstadt, Germany, each a subsidiary of Merck KGaA, Darmstadt, Germany (Annex A of the framework deed, Operational Hive-Down Agreement)

Hive-down and transfer agreement between Merck KGaA, Darmstadt, Germany, Merck Healthcare Holding GmbH, Darmstadt, Germany, Merck Life Science Holding GmbH, Darmstadt, Germany, and Merck Performance Materials Holding GmbH, Darmstadt, Germany, each a subsidiary of Merck KGaA, Darmstadt, Germany (Annex B of the framework deed, Holding Hive-Down Agreement)

Business lease agreement between Merck Healthcare Germany GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany, and Merck KGaA, Darmstadt, Germany (Annex C of the framework deed)

Business lease agreement between Merck Life Science Germany GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany, and Merck KGaA, Darmstadt, Germany (Annex D of the framework deed)

Business lease agreement between Merck Performance Materials Germany GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany, and Merck KGaA, Darmstadt, Germany (Annex E of the framework deed)

Report of Warth & Klein Grant Thornton AG Wirtschaftsprüfungsgesellschaft on the audit of the business lease agreement between Merck Healthcare Germany GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany, and Merck KGaA, Darmstadt, Germany, pursuant to Sec. 292 (1) no. 3 AktG in conjunction with Sec. 293b AktG

Report of Warth & Klein Grant Thornton AG Wirtschaftsprüfungsgesellschaft on the audit of the business lease agreement between Merck Life Science Germany GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany, and Merck KGaA, Darmstadt, Germany, pursuant to Sec. 292 (1) no. 3 AktG in conjunction with Sec. 293b AktG

Report of Warth & Klein Grant Thornton AG Wirtschaftsprüfungsgesellschaft on the audit of the business lease agreement between Merck Performance Materials Germany GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany, and Merck KGaA, Darmstadt, Germany, pursuant to Sec. 292 (1) no. 3 AktG in conjunction with § 293b AktG

Single entity annual financial statements of Merck KGaA, Darmstadt, Germany

Single entity annual financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2017 including the combined management report and supervisory board report 

Single entity annual financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2016 including the combined management report and supervisory board report 

Single entity annual financial statements of Merck KGaA, Darmstadt, Germany for the fiscal year 2015 including the combined management report and supervisory board report 

Other annual financial statements 

Annual financial statements of Merck Healthcare Germany GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany

English
2017 (PDF)
2016 (PDF)

German
2017 (PDF)
2016 (PDF)

Annual financial statements of Merck Life Science Germany GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany

English
2017 (PDF)
2016 (PDF)
2015 (PDF)

German
2017 (PDF)
2016 (PDF)
2015 (PDF)

Annual financial statements of Merck Performance Materials Germany GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany

English
2017 (PDF)
2016 (PDF)
2015 (PDF)

German
2017 (PDF)
2016 (PDF)
2015 (PDF)

Annual financial statements of Merck Healthcare Holding GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany

Annual financial statements of Merck Life Science Holding GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany

Annual financial statements of Merck Performance Materials Holding GmbH, Darmstadt, Germany, a subsidiary of Merck KGaA, Darmstadt, Germany

Annual reports with consolidated financial statements of Merck KGaA, Darmstadt, Germany

Annual report of Merck KGaA, Darmstadt, Germany, for the fiscal year 2017 including the consolidated financial statements, combined management report and supervisory board report

Annual report of Merck KGaA, Darmstadt, Germany, for the fiscal year 2016 including the consolidated financial statements, combined management report and supervisory board report

Annual report of Merck KGaA, Darmstadt, Germany, for the fiscal year 2015 including the consolidated financial statements, combined management report and supervisory board report

Additional Information

Voting Results

Chairman´s report at the Annual General Meeting 2018 (Printversion)

Webcast of the AGM 2018

Explanation of shareholder rights / German version

Information on participation – exercise of proxy voting

Sample of the Agenda Voting Card

Articles of Association of Merck KGaA, Darmstadt, Germany

PDF